Comparison of Effects and side effects between two variations of treatment modalities in Schizophrenia
Not Applicable
Completed
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2020/11/029184
- Lead Sponsor
- Dr Sukriti Mukherjee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
i)Patients of either Sex aged between 18-60 years.
ii)Right handed patients as assessed by Sidedness Bias Schedule (Mandal et al., 1992)
iii)Diagnosis of Schizophrenia (F20.0 to F20.9) according to ICD 10, having clinical indication for Electroconvulsive therapy.
iv)Patients giving written informed Consent.
Exclusion Criteria
i)Patients having predominant Catatonic symptoms
ii)Any other Psychiatric comorbidity
iii)Significant Neurological or Medical illness
iv)Female patients who are Pregnant during the study period.
v)Patients using any psychoactive substances in dependence pattern. (Except Caffeine and Nicotine)
vi)Patients on Clozapine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Right Unilateral Ultra Brief Pulse ECT will have the same efficacy as Bilateral Ultra Brief Pulse ECT in Schizophrenia patientsTimepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method Right Unilateral Ultra Brief Pulse ECT will have better cognitive side effect profile compared to Bilateral Ultra Brief Pulse ECT in Schizophrenia patientsTimepoint: 2 weeks